In conclusion, combined with literature reports and our findings, FOXM1, FTCD, CCNA2, AURKA, and CDC20 are very competitive biomarkers of HCC, while whether CDKN3 can be regarded as a biomarker for HCC remains further studies. This evidence concerns the gene CDC20 and hepatocellular carcinoma.